CLINICAL_TRIALS
trial_result
· 2012-08-09
Clinical Trial Update: GM1 Ganglioside Effects on Parkinson's Disease [Phase 2]
Summary
This document reports the completion of a Phase 2 trial evaluating GM1 ganglioside for Parkinson disease, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Thomas Jefferson University | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-08-09